Egtazic Acid

Egtazic Acid

SCHEMBL7200211

O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O.[Cu]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.95
PMP22 Q01453 2/20 0.95
HSD17B10 Q99714 1/20 0.95
TDP1 Q9NUW8 2/20 0.59
EYA2 O00167 1/20 0.59
APP P05067 1/20 0.59
ACE P12821 1/20 0.59
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
CHRM2 P08172 1/20 0.56
ADRA2A P08913 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
DRD1 P21728 1/20 0.56
SLC6A2 P23975 1/20 0.56
SLC6A4 P31645 1/20 0.56
CYP2C19 P33261 1/20 0.56
ADRA1A P35348 1/20 0.56
DRD3 P35462 1/20 0.56
SLC6A3 Q01959 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Egtazic Acid SCHEMBL22901 0.98 BLM (1.00) BLMPMP22HSD17B10TDP1EYA2
SCHEMBL11684972 0.98 BLM (1.00) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL920203 0.98 BLM (1.00) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL5067266 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL15413556 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL23859106 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL831877 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL7541607 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL456238 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2
Egtazic Acid SCHEMBL456632 0.95 BLM (0.95) BLMPMP22HSD17B10TDP1EYA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6042848-A FOR CONTROLLING GROWTH OF UNDESIRABLE OR PATHOGENIC MICROORGANISMS IN VARIOUS LOCI OR MILIEU IN, ON, OR OUTSIDE THE BODY EMPLOYING ANTIMICROBIAL PEPTIDES AND METAL IONS THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2000-03-28 US claimed
EP-0920327-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS Southern Illinois University (US) 1999-06-09 EP claimed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 WO claimed
WO-2024074809-A1 FUNGICIDAL AGENT AND COMPOSITION INNOSPEC LIMITED (GB) 2024-04-11 WO disclosed
EP-2709714-B1 APPARATUS FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD INNOVOLINK LLC (US) 2019-01-16 EP disclosed
US-9956028-B2 Apparatus and method for heating biological targets INNOVOLINK, LLC (US) 2018-05-01 US disclosed
US-9901742-B2 Apparatus and method for heating a treatment region with an alternating electric field INNOVOLINK, LLC (US) 2018-02-27 US disclosed
US-9901387-B2 Apparatus and method for heating adipose cells INNOVOLINK, LLC (US) 2018-02-27 US disclosed
US-9675814-B2 Apparatus and method for obtaining a substantially constant current across a treatment region INNOVOLINK, LLC (US) 2017-06-13 US disclosed
EP-2709714-A1 APPARATUS AND METHOD FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD Innovolink, LLC (US) 2014-03-26 EP disclosed
WO-2012154736-A1 APPARATUS AND METHOD FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD INNOVOLINK, LLC (US) 2012-11-15 WO disclosed
US-20120290048-A1 Apparatus and Method for Heating a Treatment Region with an Alternating Electric Field INNOVOLINK, LLC 2012-11-15 US disclosed
US-20120290050-A1 Apparatus and Method for Obtaining a Substantially Constant Current Across a Treatment Region INNOVOLINK, LLC 2012-11-15 US disclosed
US-20120289955-A1 Apparatus and Method for Heating Biological Targets INNOVOLINK, LLC 2012-11-15 US disclosed
US-20120289956-A1 Apparatus and Method for Heating Adipose Cells INNOVOLINK, LLC 2012-11-15 US disclosed
US-20120290049-A1 Apparatus and Method for Providing a Substantially Constant Voltage Between Electrodes Extending Across a Treatment Region INNOVOLINK, LLC 2012-11-15 US disclosed
WO-2003051281-A2 COMPOSITION AND METHOD TO TREAT VIRAL BACTERIAL AND PARASITIC INFECTIONS AND INFESTATIONS GANADO RESEARCH, L.L.C. (US) 2003-06-26 WO disclosed
US-6042848-A FOR CONTROLLING GROWTH OF UNDESIRABLE OR PATHOGENIC MICROORGANISMS IN VARIOUS LOCI OR MILIEU IN, ON, OR OUTSIDE THE BODY EMPLOYING ANTIMICROBIAL PEPTIDES AND METAL IONS THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2000-03-28 US disclosed
EP-0920327-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS Southern Illinois University (US) 1999-06-09 EP disclosed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 WO disclosed